New York State Teachers Retirement System (NYSTRS)’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
Other funds holding ITOS
RCM
MAM
BC
MB
BI
EC
New York State Teachers Retirement System (NYSTRS)'s ITOS Position: Q4 2023 in Review
New York State Teachers Retirement System (NYSTRS) sold out of iTeos Therapeutics (ITOS) in Q4 2023, closing a stake of 27,200 shares — an estimated $298K sold.
New York State Teachers Retirement System (NYSTRS) first reported a position in ITOS in Q1 2022 and held it in 7 quarters. The position peaked at $569K in Q4 2022. 138 funds tracked by Wall St. Rank hold ITOS as of Q4 2023.
- New York State Teachers Retirement System (NYSTRS) reported no remaining iTeos Therapeutics position as of Q4 2023 after selling out during the quarter.
- New York State Teachers Retirement System (NYSTRS) sold 27,200 iTeos Therapeutics shares in Q4 2023, an estimated $298K.
- New York State Teachers Retirement System (NYSTRS) first reported a position in iTeos Therapeutics in Q1 2022 and held it in 7 quarters.
- New York State Teachers Retirement System (NYSTRS)'s iTeos Therapeutics position peaked at $569K in Q4 2022.
- 138 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q4 2023.
Based on New York State Teachers Retirement System (NYSTRS)'s 13F filing for Q4 2023, filed 24 Jan 2024.